PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

38 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Sunami, Y.* et al.: Canonical NF-kappa B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 63, 1, 233A-233A (2016)
22.
Thomsen, M.K.* et al.: Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection. Hepatology 64, 746-759 (2016)
23.
Endig, J.* et al.: CD8+ T-cells drive liver injury and hepatocellular carcinoma in chronic liver disease. Hepatology 62, 1244A (2015)
24.
Li, Y.* et al.: IFN-α-mediated base excision repair pathway correlates with antiviral response against Hepatitis B Virus infection. Hepatology 62, 1030A (2015)
25.
Seubert, B.* et al.: TIMP-1 creates a pre-metastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology 61, 238-248 (2015)
26.
Hösel, M.* et al.: Hepatitis B virus infection enhances susceptibility towards adeno-associated viral vector transduction in vitro and in vivo. Hepatology 59, 2110-2120 (2014)
27.
Ellinghaus, D.* et al.: Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 58, 1074-1083 (2013)
28.
Jeliazkova, P.* et al.: Canonical notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology 57, 2469-2479 (2013)
29.
Sprinzl, M.F. et al.: Sorafenib perpetuates cellular anti-cancer effector functions by modulating the cross talk between macrophages and natural killer cells. Hepatology 57, 2358-2368 (2013)
30.
Xia, Y. et al.: Interferons induce degradation of HBV CccDNA. Hepatology 58, 274A-275A (2013)
31.
Hösel, M.* et al.: Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 55, 287-297 (2012)
32.
Stross, L. et al.: Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology 56, 873-883 (2012)
33.
Stabenow, D.* et al.: Bioluminescence imaging allows measuring CD8 T cell function in the liver. Hepatology 51, 1430-1437 (2010)
34.
Haring, R.* et al.: Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 50, 1403-1411 (2009)
35.
Hösel, M.* et al.: Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50, 1773-1782 (2009)
36.
Xing, X.* et al.: Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy. Hepatology 49, 979-988 (2009)
37.
Geisler, F.* et al.: Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 48, 607-616 (2008)
38.
Rollier, C.S.* et al.: Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 45, 602-613 (2007)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮